Novel homozygous mutation in SCNN1A gene in an Iranian boy with PHA1B
Journal of Pediatric Endocrinology and Metabolism · 2024
DOI: 10.1515/jpem-2023-0505 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, 2024. Verfasst von Fatemeh Saffari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Children Growth Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran. Hauptthemen laut MEDLINE: Pseudohypoaldosteronism, Mutation, Homozygote, Epithelial Sodium Channels. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Objectives
Pseudohypoaldosteronism type 1 (PHA1) has two genetically distinct variants, including renal and systemic forms. Systemic PHA type I (PHA1B) has varying degrees of clinical presentation and results from mutations in genes encoding subunits of the epithelial sodium channel (ENaC) including the alpha, beta, and gamma subunits. To date, about 45 variants of PHA1B have been identified. Case presentation We report a boy with PHA1B, who presented with vomiting, lethargy, and poor feeding due to salt wasting six days after birth. The patient had electrolyte imbalances. A novel SCNN1A (sodium channel epithelial subunit alpha) gene mutation, NM_001038.6:c.1497G>C, with an autosomal recessive pattern, was identified by whole exosome sequencing. This variant was inherited as a homozygote from both heterozygous parents.
Conclusions
PHA should be considered in neonates with hyponatremia and hyperkalemia. This case report presents a patient with a novel mutation in SCNN1A that has not been previously reported. Long-term follow-up of identified patients to understand the underlying phenotype-–genotype link is necessary.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Children Growth Research Center, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran.
- School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
- School of Medicine, Harvard University, Boston, USA.
- Cellular and Molecular Research Centre, Research Institute for Prevention of Non-Communicable Diseases, Qazvin University of Medical Sciences, Qazvin, Iran.
ORCID-Profile: Sahar Moghbelinejad
Zitieren
APA
Saffari, F., Bahadoran, E., Homaei, A., & Moghbelinejad, S. (2024). Novel homozygous mutation in SCNN1A gene in an Iranian boy with PHA1B. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2023-0505
Vancouver
Saffari F, Bahadoran E, Homaei A, Moghbelinejad S. Novel homozygous mutation in SCNN1A gene in an Iranian boy with PHA1B. Journal of Pediatric Endocrinology and Metabolism. 2024. doi:10.1515/jpem-2023-0505
BibTeX
@article{Saffari2024,
author = {Saffari, Fatemeh and Bahadoran, Ensiyeh and Homaei, Ali and Moghbelinejad, Sahar},
title = {Novel homozygous mutation in SCNN1A gene in an Iranian boy with PHA1B},
journal = {Journal of Pediatric Endocrinology and Metabolism},
year = {2024},
doi = {10.1515/jpem-2023-0505}
}
EUVIMED